Oppenheimer analyst Francois Brisebois upgraded DiaMedica Therapeutics to Outperform from Perform with a $7 price target.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on DMAC: